Diagnosis of Oral Precancers & Cancers Using Optic NCT00172965

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Details — Status: Recruiting

Study information
Verified date	August 2004
Source	National Taiwan University Hospital
Contact	Chun-Pin Chiang, DMSc
Phone	886-2-23123456
Email	cpchiang[@]ha.mc.ntu.edu.tw
Is FDA regulated	No
Health authority	Taiwan: Department of Health
Study type	Observational

Diagnosis of oral precancers and cancers using optic coherence tomography

Diagnosis of oral precancers and cancers using optic coherence tomography

Recruitment information / eligibility
Status	Recruiting
Enrollment	60
Est. completion date	June 2005
Est. primary completion date
Accepts healthy volunteers	Accepts Healthy Volunteers
Gender	Both
Age group	18 Years to 85 Years
Eligibility	Inclusion Criteria: - oral cancer, oral precancers Exclusion Criteria: - other diseases

Observational Model: Defined Population, Primary Purpose: Screening, Time Perspective: Cross-Sectional

Locations
Country	Name	City	State
Taiwan	National Taiwan University Hospital	Taipei

Sponsors *(1)*
Lead Sponsor	Collaborator
National Taiwan University Hospital

Taiwan,